ID   MS0812
AC   CVCL_IK99
DR   Wikidata; Q54906797
RX   Patent=CN1904037A;
RX   PubMed=19724881;
CC   Group: Patented cell line.
CC   Population: Chinese.
CC   Doubling time: ~24 hours (PubMed=19724881).
DI   NCIt; C6476; Dedifferentiated chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   10FW
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 21-03-23; Version: 7
//
RX   Patent=CN1904037A;
RA   Yang L., Zheng J.-K., Chen Q., Huang T.-H., Li W.-Y., Wen J.-C.,
RA   Liu G.-Y., Zhang S.;
RT   "New sarcoma cell line, its establishing method and application.";
RL   Patent number CN1904037A, 31-Jan-2007.
//
RX   PubMed=19724881; DOI=10.3892/ijmm_00000249;
RA   Yang L.-Y., Chen Q., Zhang S., Wang X.-Y., Li W.-Y., Wen J.-C.,
RA   Huang X.-P., Zheng J.-K., Huang G., Huang T.-H., Ju G.-Z.;
RT   "A novel mutated cell line with characteristics of dedifferentiated
RT   chondrosarcoma.";
RL   Int. J. Mol. Med. 24:427-435(2009).
//